{"organizations": ["Portal Instruments"], "uuid": "0c999fa9c51d61f9072c5e6d78125ace8e846594", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.pharmamedtechbi.com", "main_image": "", "site_section": "http://feeds.feedburner.com/PharmaBiotechFinancing", "section_title": "Pharma/Biotech Financing From Elsevier Business Intelligence", "url": "https://www.pharmamedtechbi.com/deals/201530767?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "country": "IL", "title": "Portal Instruments raises $25mm in Series B capital", "performance_score": 0, "site": "pharmamedtechbi.com", "participants_count": 0, "title_full": "Portal Instruments raises $25mm in Series B capital", "spam_score": 0.0, "site_type": "news", "published": "2015-10-22T02:40:00.000+03:00", "replies_count": 0, "uuid": "0c999fa9c51d61f9072c5e6d78125ace8e846594"}, "author": "", "url": "https://www.pharmamedtechbi.com/deals/201530767?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "ord_in_thread": 0, "title": "Portal Instruments raises $25mm in Series B capital", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Portal Instruments raises $25mm in Series B capital Deal Date: Oct-01-2015 / Deal # 201530767 Executive Summary \nDrug delivery device company Portal Instruments Inc. raised $25mm in a Series B preferred stock round led by 5AM Ventures. The company's existing investors including Sanofi-Sunrise also participated. $10mm was received up-front, with an additional $15mm expected following achievement of certain milestones. Proceeds will be used to further develop Portal's computerized needle-free drug delivery system for injectable biologics for chronic diseases. The technology is supported by an IP portfolio of over 50 patents conceived at Massachusetts Institute of Technology .", "external_links": [], "published": "2015-10-22T02:40:00.000+03:00", "crawled": "2015-10-22T19:22:34.255+03:00", "highlightTitle": ""}